Publication & Citation Trends
Publications
22 total
MON-749 Long-Term in Vivo Expression of Tissue Nonspecific Alkaline Phosphatase by Ex Vivo Gene Edited B Cells as a Potential Treatment of Hypophosphatasia PDF
Cited by 0
OpenAlex
Corrigendum to “Challenges and opportunities in gene editing of B cells” [Biochem. Pharmacol. 206 (2022) 115285] PDF
Cited by 0
OpenAlex
Engineering a “muco‐trapping” <scp>ACE2</scp> ‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for <scp>COVID</scp> ‐19 PDF
Cited by 5
OpenAlex
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population PDF
Cited by 2
OpenAlex
Challenges & opportunities for phage-based in situ microbiome engineering in the gut PDF
Cited by 1
OpenAlex
Corrigendum to “Challenges and opportunities in gene editing of B cells” [Biochem. Pharmacol. 206 (2022) 115285]
Cited by 1
OpenAlex
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines PDF
Cited by 169
OpenAlex
Research Topics
CRISPR and Genetic Engineering
(8)
CAR-T cell therapy research
(7)
Virus-based gene therapy research
(6)
Nanoparticle-Based Drug Delivery
(4)
Polymer Surface Interaction Studies
(2)
Affiliations
University of North Carolina at Chapel Hill
Biogen (United States)
Virginia Commonwealth University
Princeton University
American Pharmacists Association